ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Andrew Wilner, MD

Andrew Wilner, MD

Dr. Wilner graduated from Yale University and Brown University School of Medicine. He is board certified in internal medicine and neurology. He completed a fellowship in electroencephalography at the Montreal Neurological Institute, Montreal, Canada. He was medical director of the Carolinas Epilepsy Center, Charlotte, NC, and then served as Clinical Associate Professor of Neurology at Brown University School of Medicine, Providence, RI.

Currently, he is a neurologist, medical journalist, and medical advisor for Accordant Health Services Epilepsy Disease Management Program, Greensboro, NC. He is a fellow of the American Academy of Neurology and a Fellow of the American College of Physicians.

Dr. Wilner has a lifelong interest in writing fiction and nonfiction, and writes for many medical and other publications. He received the American Academy of Neurology's Creative Expression of Human Values Award (2001), the American Academy of Neurology's Journalism Fellowship for Excellence in Medical/Health Reporting (2008), and is the author of two books on epilepsy; Epilepsy: 199 Answers, 3rd Edition, and Epilepsy in Clinical Practice. He was a Section Editor for the 3-volume Atlas of Epilepsies (Springer, 2010). His newest book, Bullets and Brains, a collection of over 100 essays on neurology, was published in 2013.

Dr. Wilner volunteers as the medical director of Lingkod Timog, a nonprofit medical mission organization that delivers health care to rural areas of the Philippines. For more information, see www.drwilner.org and bulletsandbrains.net.
 

Posts by Author

The possibility of SUDEP should serve as a powerful motivator for improved adherence and active attempts at seizure control with new medications, neurostimulation, and epilepsy surgery.

Choosing a technique for a particular drug resistant patient is a judgment call based on the results of the patient’s monitoring, clinician experience, and many other factors.

At the ACTRIMS/ECTRIMS conference, one has the impression that the science of multiple sclerosis is moving forward at an unprecedented rapid rate. Live from the floor . . .

The knowledge that a patient is at high or low risk for late seizures has the potential to improve patient care.

Persons with epilepsy have a higher prevalence of comorbid conditions—psychiatric disorders in particular—than the general population. Here: a look at the most common comorbidities and a discussion of the clinical implications.

By clicking Accept, you agree to become a member of the UBM Medica Community.